Emerging role of B cells in chronic allograft dysfunction

31Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

B cells have many possible mechanisms by which they can affect allograft survival, including antigen presentation, cytokine production, immune regulation, and differentiation into alloantibody-producing plasma cells. This report reviews the last mechanism, which the authors regard as most critical for the long-term survival of allografts, namely, the promotion of chronic rejection by alloantibodies. Chronic humoral rejection characteristically arises late after transplantation and causes transplant glomerulopathy, multilamination of peritubular capillary basement membranes, and C4d deposition in PTCs and glomeruli. Circulating antidonor human leukocyte antigen class II antibodies are commonly detected and may precede the development of graft injury. Prognosis is poor, especially when recognized after graft dysfunction has developed. Improved detection and treatment are critically needed for this common cause of late graft loss. © 2010 International Society of Nephrology.

Cite

CITATION STYLE

APA

Colvin, R. B., Hirohashi, T., Farris, A. B., Minnei, F., Collins, A. B., & Smith, R. N. (2010). Emerging role of B cells in chronic allograft dysfunction. In Kidney International (Vol. 78). Nature Publishing Group. https://doi.org/10.1038/ki.2010.436

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free